BioCentury
ARTICLE | Clinical News

Lebrikizumab regulatory update

October 22, 2012 7:00 AM UTC

Roche disclosed in its 3Q12 earnings that it will delay submission of regulatory applications for asthma candidate lebrikizumab to after 2016. The pharma said it identified the need to optimize manufa...